Full Text View
Tabular View
No Study Results Posted
Related Studies
Difluoromethylornithine (DFMO) Chemoprevention of Skin Cancer in Organ Transplant Recipients
This study has been completed.
Study NCT00204789   Information provided by University of Wisconsin, Madison
First Received: September 12, 2005   Last Updated: December 21, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Post-Solid Organ Transplant
Skin Neoplasms
Additional conditions recognized in this trial
Neoplasms
More general conditions related to this trial
Neoplasms by Site
Skin Diseases
Interventions listed in this trial
Difluoromethylornithine
Additional drug interventions recognized in this trial
Eflornithine
More general drug interventions related to this trial
Anti-Infective Agents
Antineoplastic Agents
Antiparasitic Agents
Antiprotozoal Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Trypanocidal Agents
Sponsors listed in this trial
University of Wisconsin, Madison


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services